Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity-Reference-Cited by-同舟云学术

Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity

Published:2007-10-01 Issue:10 Volume:117 Page:3087-3096
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Russo Vincenzo,Cipponi Arcadi,Raccosta Laura,Rainelli Cristina,Fontana Raffaella,Maggioni Daniela,Lunghi Francesca,Mukenge Sylvain,Ciceri Fabio,Bregni Marco,Bordignon Claudio,Traversari Catia

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference44 articles.

1. Tumor-specific shared antigenic peptides recognized by human T cells

2. Dendritic cells and the control of immunity

3. The Immunobiology of Cancer Immunosurveillance and Immunoediting

4. Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

5. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells;Journal of Clinical Investigation;2021-08-16

2. Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting;Cancers;2020-03-05

3. Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses;Journal of Clinical Investigation;2020-01-06

4. Therapeutic Regeneration of Lymphatic and Immune Cell Functions upon Lympho-organoid Transplantation;Stem Cell Reports;2019-06

5. Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes;Frontiers in Immunology;2019-05-29